Drug intelligence / Profile preview

Cremin Complex

Development stage
Discontinued
Lead developer
Shanghai Sixth People’s Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Cremin Complex is a combination pharmaceutical preparation developed by Shanghai Sixth People's Hospital for the treatment of attention deficit hyperactivity disorder (ADHD). The formulation consists of clemastine, an H1-receptor antagonist, along with vitamin B6 (pyridoxine) and glutamic acid. Clemastine is included for its sedative properties and its ability to cross the blood-brain barrier, which was historically utilized in China to manage symptoms of hyperactivity and impulsivity in pediatric patients. Vitamin B6 acts as a cofactor in the synthesis of essential neurotransmitters such as dopamine, serotonin, and GABA, while glutamic acid serves as a metabolic support for brain function. Although once a common hospital-made preparation (医院制剂) in Shanghai during the late 20th century, its use has largely been superseded by more targeted ADHD medications like methylphenidate and atomoxetine.

Brand names
Cremin Complex克力敏复合剂Keliming Fuheji
Other names
Clemastine + Vitamin B6 + Glutamic acid克力敏复合片Keliming Complex
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Cremin Complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cremin Complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call